Cas:5737-13-3 4H-Cyclopenta[def]phenanthren-4-one manufacturer & supplier

Chemical Name:4H-Cyclopenta[def]phenanthren-4-one

CAS.NO:5737-13-3

Synonyms:4H-cyclopenta[def]phenanthrene-4-one;cyclopenta<def>phenanthren-4-one;cyclopenta[def]phenanthrene-4-one;4H-cyclopenta<def>phentanthren-4-one;4H-Cyclopenta[def]phenanthren-4-one;4H-cyclopenta(def)phenanthren-4-one;BCR338_FLUKA

Molecular Formula:C₁₅H₈O

Molecular Weight:204.223

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:411.6±12.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.832

PSA:17.07000

Exact Mass:204.057510

LogP:3.96

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4H-cyclopenta[def]phenanthrene-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,BCR338_FLUKA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4H-Cyclopenta[def]phenanthren-4-one Use and application,BCR338_FLUKA technical grade,usp/ep/jp grade.

Related News: According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter. 4H-Cyclopenta[def]phenanthren-4-one manufacturer China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. 4H-Cyclopenta[def]phenanthren-4-one supplier Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities. 4H-Cyclopenta[def]phenanthren-4-one vendor China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. 4H-Cyclopenta[def]phenanthren-4-one factory A number of factors influenced the decision by the U.S. Centers for Disease Control and Prevention, including the COVID-19 pandemic, too few facilities to quarantine dogs safely and three recent incidents where rabies-infected dogs were brought into the country, CNN reported.